UACJ Corporation
TSE:5741 Stock Report
UACJ Balance Sheet Health
Financial Health criteria checks 5/6 UACJ has a total shareholder equity of ¥317.4B and total debt of ¥326.4B, which brings its debt-to-equity ratio to 102.8%. Its total assets and total liabilities are ¥943.6B and ¥626.2B respectively. UACJ's EBIT is ¥53.9B making its interest coverage ratio 3.3. It has cash and short-term investments of ¥30.8B.
Key information
102.8%
Debt to equity ratio
Interest coverage ratio 3.3x Cash JP¥30.82b Equity JP¥317.39b Total liabilities JP¥626.18b Total assets JP¥943.57b
Recent financial health updates
Show all updates
Second quarter 2025 earnings: EPS and revenues miss analyst expectations Nov 11
Price target increased by 7.1% to JP¥5,435 Sep 20
Upcoming dividend of JP¥70.00 per share Sep 20
Consensus EPS estimates increase by 11% Sep 03
Market Participants Recognise UACJ Corporation's (TSE:5741) Earnings Pushing Shares 25% Higher Aug 19
A Look At The Intrinsic Value Of UACJ Corporation (TSE:5741) Aug 09
Now 24% undervalued after recent price drop Aug 02
UACJ Corporation to Report Q2, 2025 Results on Nov 07, 2024 Jul 29
UACJ (TSE:5741) Is Posting Promising Earnings But The Good News Doesn’t Stop There Jul 12
Final dividend of JP¥50.00 announced Jul 11
Is UACJ (TSE:5741) A Risky Investment? Jun 14
An undisclosed buyer acquired 5.44% stake in UACJ Corporation (TSE:5741) from Furukawa Electric Co., Ltd. (TSE:5801). Jun 11
An undisclosed buyer acquired 5.44% stake in UACJ Corporation (TSE:5741) from Furukawa Electric Co., Ltd. (TSE:5801). Jun 10
Full year 2024 earnings: EPS and revenues exceed analyst expectations May 16
UACJ Corporation, Annual General Meeting, Jun 19, 2024 May 15
Consensus EPS estimates fall by 15% May 14
Now 20% overvalued after recent price rise Apr 12
Price target increased by 7.8% to JP¥4,740 Apr 10
Upcoming dividend of JP¥45.00 per share Mar 21
Now 25% overvalued after recent price rise Mar 21
A Look At The Intrinsic Value Of UACJ Corporation (TSE:5741) Mar 07 UACJ Corporation to Report Q3, 2025 Results on Feb 12, 2025
Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind Feb 10
Now 22% overvalued after recent price rise Feb 09
UACJ Corporation to Report Fiscal Year 2024 Results on May 13, 2024 Feb 08
Price target increased by 8.7% to JP¥3,932 Jan 31
Now 21% overvalued after recent price rise Jan 25
Price target increased by 8.7% to JP¥3,740 Jan 12
Price target increased by 9.9% to JP¥3,617 Dec 04
Second quarter 2024 earnings: EPS and revenues miss analyst expectations Nov 10
New minor risk - Share price stability Aug 04
First quarter 2024 earnings released: EPS: JP¥60.70 (vs JP¥295 in 1Q 2023) Aug 04
Investor sentiment improves as stock rises 16% Aug 04
Consensus EPS estimates fall by 25% Jun 10
Consensus EPS estimates fall by 27%, revenue upgraded May 23
Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind May 14
UACJ Corporation, Annual General Meeting, Jun 21, 2023 May 11
Upcoming dividend of JP¥85.00 per share at 3.2% yield Mar 23
Consensus EPS estimates increase by 16%, revenue downgraded Mar 03
Investor sentiment improves as stock rises 15% Feb 21
Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Feb 09 UACJ Corporation to Report Fiscal Year 2023 Results on May 11, 2023 Feb 07
Consensus forecasts updated Dec 13
Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Nov 18
Less than half of directors are independent Nov 16
Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind Nov 10
Price target increased to JP¥3,169 Aug 30
First quarter 2023 earnings: EPS and revenues exceed analyst expectations Aug 05
Investor sentiment improved over the past week Aug 05
Full year 2022 earnings: EPS exceeds analyst expectations May 15
Less than half of directors are independent Apr 27 UACJ Corporation to Report Q2, 2023 Results on Nov 08, 2022
Price target decreased to JP¥2,970 Mar 17
Consensus forecasts updated Mar 15
Consensus forecasts updated Mar 10
Investor sentiment deteriorated over the past week Mar 09
Now 24% undervalued after recent price drop Mar 07
Third quarter 2022 earnings: EPS and revenues miss analyst expectations Feb 04
Consensus EPS estimates increase to JP¥520 Nov 27
Second quarter 2022 earnings released: EPS JP¥177 (vs JP¥101 loss in 2Q 2021) Nov 05
Investor sentiment improved over the past week Sep 13
Investor sentiment deteriorated over the past week Aug 20
First quarter 2022 earnings released: EPS JP¥182 (vs JP¥3.57 loss in 1Q 2021) Aug 09
Price target increased to JP¥3,090 Jun 30
Full year 2021 earnings released: JP¥67.78 loss per share (vs JP¥42.25 profit in FY 2020) May 14
Price target raised to JP¥2,210 Feb 26
New 90-day high: JP¥2,514 Feb 25
UACJ Corporation to Report Fiscal Year 2021 Results on May 12, 2021 Feb 17
Third quarter 2021 earnings released: EPS JP¥7.61 (vs JP¥81.87 in 3Q 2020) Feb 06
Earnings beat expectations, revenue disappoints Feb 06
New 90-day high: JP¥2,314 Feb 05
New 90-day high: JP¥1,987 Dec 18
Analysts update estimates Dec 13
Analysts lower EPS estimates to -JP¥176 Dec 01
UACJ Corporation to Report Q3, 2021 Results on Feb 04, 2021 Nov 07
Senko Co., Ltd. entered into a stock transfer agreement to acquire 66.7% stake in Uacj Butsuryu Co.,Ltd from UACJ Corporation (TSE:5741) for ¥3.1 billon. Aug 29
UACJ Corporation to Report Q2, 2021 Results on Nov 05, 2020 Aug 16
UACJ Corporation To Be Deleted From Other OTC Jul 22
Financial Position Analysis
Short Term Liabilities: 5741's short term assets (¥465.6B) exceed its short term liabilities (¥393.9B).
Long Term Liabilities: 5741's short term assets (¥465.6B) exceed its long term liabilities (¥232.2B).
Debt to Equity History and Analysis
Debt Level: 5741's net debt to equity ratio (93.1%) is considered high .
Reducing Debt: 5741's debt to equity ratio has reduced from 184.5% to 102.8% over the past 5 years.
Debt Coverage: 5741's debt is well covered by operating cash flow (29.1%).
Interest Coverage: 5741's interest payments on its debt are well covered by EBIT (3.3x coverage).
Discover healthy companies Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
